Viewing Study NCT02937818

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 4:49 AM

Ignite Modification Date: 2026-04-11 @ 1:02 PM

Study NCT ID: NCT02937818

Status: COMPLETED

Last Update Posted: 2024-06-07

First Post: 2016-10-05

Is NOT Gene Therapy: True

Has Adverse Events: True

Brief Title: A Phase II, Study to Determine the Preliminary Efficacy of Novel Combinations of Treatment in Patients With Platinum Refractory Extensive-Stage Small-Cell Lung Cancer

Sponsor: AstraZeneca

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module Adverse Events Module Baseline Characteristics Module Participant Flow Module